Company Filing History:
Years Active: 2009-2021
Title: Innovations by Moshe Ben-David in Antimicrobial Susceptibility Testing
Introduction
Moshe Ben-David is an accomplished inventor based in Tel Aviv, Israel. He has made significant contributions to the field of antimicrobial susceptibility testing, holding three patents that enhance the ability to determine the effectiveness of antibiotics against bacterial infections. His work is particularly relevant in the context of rising antibiotic resistance and the need for rapid diagnostic methods.
Latest Patents
Ben-David's latest patents focus on rapid antimicrobial susceptibility testing through innovative techniques. One of his notable inventions is a method based on a unique spectral intensity ratio analysis via single fluorescence membrane dye staining and flow cytometry. This method allows for the determination of the Minimum Inhibitory Concentration (MIC) of antibiotics, providing clinicians with a quick and effective means to identify suitable treatment regimens for patients suffering from bacterial infections, including those that may lead to sepsis. Another patent involves a rapid antibiotic susceptibility test that utilizes membrane fluorescence staining and spectral intensity ratio, further improving the accuracy of the dead to live population ratio in bacterial samples.
Career Highlights
Throughout his career, Moshe Ben-David has worked with several prominent companies in the diagnostics field. He has been associated with Pocared Diagnostics Ltd. and Atlantium Technologies Ltd., where he has contributed to the development of innovative solutions for healthcare challenges. His expertise in antimicrobial susceptibility testing has positioned him as a key figure in advancing medical diagnostics.
Collaborations
Ben-David has collaborated with notable professionals in his field, including Gal Ingber and Eran Zahavy. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Moshe Ben-David's contributions to antimicrobial susceptibility testing represent a significant advancement in medical diagnostics. His innovative patents provide essential tools for clinicians, enabling rapid and accurate treatment decisions for bacterial infections. His work continues to influence the healthcare landscape positively.